Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Q4 2023 update: renewable energy related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that renewable energy accounted for 2 pharmaceutical deals announced in Q4...